Gastrointestinal disorders
Conditions
Interventions
This is a randomized, simpels-blind clinical trial. Using 30 autistic children aged 3 to 10 years. The randomization process was performed in blocks with a computer-generated list used to distribute t
Experimental Group - 15 children consumption of A2 milk bioforitified with selenium and vitamin E (500 ml/ day) during the period of 84 days.
F.84
Sponsors
Faculdade de Zootecnia e Engenharia de Alimentos da Universidade de São Paulo
Fonterra Co-operative Group Ltd
Eligibility
Age
3 Years to 10 Years
Inclusion criteria
Inclusion criteria: Child aged 3 to 10 years; male and female gender; diagnosis of Autism Spectrum Disorder (ASD) according to the evaluation criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5); being classified into one of the three grades of autism
Exclusion criteria
Exclusion criteria: Positive diagnosis for cow’s milk protein allergy. Use of antibiotics or in the last 7 days prior to the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Gastrointestinal discomfort. Oxidative stress. Serum levels of non-enzymatic (selenium, vitamin E) and enzymatic (glutathione peroxidase) antioxidants. Serum levels of immuno-inflammatory cytokines (IL-4, CRP). Serum levels of beta-casomorphin-7. IV dipeptidyl peptidase serum levels.;Milk A2 is expected to reduce gastrointestinal discomforts related to milk consumption | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected to increase the levels of antioxidants, selenium and vitamin E, and consequently increase the levels of enzymatic antioxidants such as glutathione peroxidase, catalase and suporoxide dismutase | — |
Countries
Brazil
Contacts
Public ContactAna Maria Vidal
Universidade de São Paulo
Outcome results
None listed